Anti‐Neuronal Nuclear Antibody 3 Autoimmunity Targets Dachshund Homolog 1
暂无分享,去创建一个
C. Lucchinetti | V. Lennon | S. Pittock | Yong Guo | A. McKeon | E. Flanagan | Binxia Yang | A. Zekeridou | Liang Wu
[1] J. Honnorat,et al. Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes , 2021, Neurology: Neuroimmunology & Neuroinflammation.
[2] O. Hampton,et al. DACH1 mutation frequency in endometrial cancer is associated with high tumor mutation burden. , 2020, PloS one.
[3] C. Klein,et al. Neurologic autoimmunity and immune checkpoint inhibitors , 2020, Neurology.
[4] V. Lennon,et al. Paraneoplastic autoimmunity and small‐cell lung cancer: Neurological and serological accompaniments , 2019, Thoracic cancer.
[5] A. Mammen,et al. Pre-existing antiacetylcholine receptor autoantibodies and B cell lymphopaenia are associated with the development of myositis in patients with thymoma treated with avelumab, an immune checkpoint inhibitor targeting programmed death-ligand 1 , 2018, Annals of the rheumatic diseases.
[6] V. Lennon,et al. Mutated cancer autoantigen implicated cause of paraneoplastic myasthenia gravis , 2018, Muscle & nerve.
[7] Ming-yong Wang,et al. Alteration of DACH1 methylation patterns in lung cancer contributes to cell proliferation and migration. , 2018, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[8] V. Lennon,et al. Microtubule‐associated protein 1B: Novel paraneoplastic biomarker , 2017, Annals of neurology.
[9] C. Chapman,et al. Novel Humoral Prognostic Markers in Small-Cell Lung Carcinoma: A Prospective Study , 2015, PloS one.
[10] H. Wu,et al. DACH1 inhibits SNAI1-mediated epithelial–mesenchymal transition and represses breast carcinoma metastasis , 2015, Oncogenesis.
[11] C. Klein,et al. Neural Autoantibody Clusters Aid Diagnosis of Cancer , 2014, Clinical Cancer Research.
[12] Ales Cvekl,et al. DACH1 Is a Cell Fate Determination Factor That Inhibits Cyclin D1 and Breast Tumor Growth , 2006, Molecular and Cellular Biology.
[13] V. Lennon,et al. Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome , 2004, Annals of neurology.
[14] C. Lucchinetti,et al. Anti‐neuronal nuclear autoantibody type 2: Paraneoplastic accompaniments , 2003, Annals of neurology.
[15] K. Chan,et al. ANNA‐3 anti‐neuronal nuclear antibody: Marker of lung cancer‐related autoimmunity , 2001, Annals of neurology.
[16] J. Workman,et al. Preparation of Nuclear and Cytoplasmic Extracts from Mammalian Cells , 2001, Current protocols in pharmacology.
[17] R. Darnell,et al. The neuronal nuclear antigen recognized by the human anti-Ri autoantibody is expressed in central but not peripheral nervous system neurons , 1993, Neuroscience Letters.
[18] M. Rosenblum,et al. Anti‐Hu-Associated Paraneoplastic Encephalomyelitis/Sensory Neuronopathy A Clinical Study of 71 Patients , 1992, Medicine.